| ddc | <drug> A nucleoside analogue that inhibits infection of new cells by HIV. It is FDA-approved for the treatment of HIV when used in combination with AZT in patients with CD4 cell counts below 300 who have deteriorated despite treatment and as monotherapy following AZT-failure. Possible side effects include nerve damage in the hands and feet (peripheral neuropathy) and sores in the mouth. (09 Oct 1997) |
|---|